Cargando…

Natural Killer Cell-Mediated Immunotherapy for Leukemia

SIMPLE SUMMARY: Conventional therapies such as chemotherapy and radiation in leukemia increase infection susceptibility, adverse side effects and immune cell inactivation. Natural killer (NK) cells are the first line of defense against cancer and are critical in the recognition and cytolysis of rapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allison, Michaela, Mathews, Joel, Gilliland, Taylor, Mathew, Stephen O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833963/ https://www.ncbi.nlm.nih.gov/pubmed/35159109 http://dx.doi.org/10.3390/cancers14030843

Ejemplares similares

Natural killer cell-based immunotherapy for acute myeloid leukemia
por: Xu, Jing, et al.
Publicado: (2020)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Natural Killer Cells: Angels and Devils for Immunotherapy
por: Martín-Antonio, Beatriz, et al.
Publicado: (2017)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Natural killer cells: a promising immunotherapy for cancer
por: Chu, Junfeng, et al.
Publicado: (2022)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Pharmacological targeting of natural killer cells for cancer immunotherapy
por: Miyazato, Kiho, et al.
Publicado: (2020)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

A Hot Topic: Cancer Immunotherapy and Natural Killer Cells
por: Michel, Tatiana, et al.
Publicado: (2022)

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
por: Murugan, Dhanashree, et al.
Publicado: (2022)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
por: Poon, Angie Yu Ching, et al.
Publicado: (2022)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia
por: Martner, Anna, et al.
Publicado: (2015)

The role of natural killer cells in chronic myeloid leukemia
por: Danier, Anna Carolyna Araújo, et al.
Publicado: (2011)

Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
por: Kennedy, Philippa R., et al.
Publicado: (2022)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)

In Vivo Monitoring of Natural Killer Cell Trafficking During Tumor Immunotherapy
por: Sta Maria, Naomi S, et al.
Publicado: (2014)

Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
por: Gingrich, Alicia A., et al.
Publicado: (2019)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Natural killer cell-based immunotherapy for lung cancer: Challenges and perspectives
por: Zeng, Yongqin, et al.
Publicado: (2021)

Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
por: Cazzetta, Valentina, et al.
Publicado: (2021)

The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
por: Fortes-Andrade, Tânia, et al.
Publicado: (2021)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
por: Islam, Rasa, et al.
Publicado: (2021)

Cytokine-induced memory-like natural killer cells for cancer immunotherapy
por: Tarannum, Mubin, et al.
Publicado: (2021)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Hattori, Norimichi, et al.
Publicado: (2019)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target
por: Gingrich, Alicia A., et al.
Publicado: (2021)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy
por: Kwon, Hyung-Joon, et al.
Publicado: (2017)

The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
por: Market, Marisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o2gbdqbffsjju4a9r650o95m8f